证券代码：920489 证券简称：佳先股份 公告编号：2026-011 安徽佳先功能助剂股份有限公司 2024 年年度报告及摘要更正公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别 及连带法律责任。 一、更正事项概述 安徽佳先功能助剂股份有限公司（以下简称"公司"）于 2025 年 4 月 25 日 在北京证券交易所官方信息披露平台（http://www.bse.cn）披露了《2024 年年度 报告》、《2024 年年度报告摘要》。根据《企业会计准则第 28 号—会计政策、会 计估计变更和差错更正》和《公开发行证券的公司信息披露编报规则第 19 号— 财务信息的更正及相关披露》等有关规定和要求，结合公司前期会计差错更正情 况，公司对上述公告部分内容进行更正。公司于 2026 年 1 月 28 日召开第六届董 事会第六次会议及第六届董事会审计委员会第五次会议审议通过了《关于前期会 计差错更正及追溯调整的议案》，并对已披露的《2024 年年度报告》、《2024 年年 度报告摘要》部分内容进行更正。 二、更正事项的具体内 ...

证券代码：920402 证券简称：硅烷科技 公告编号：2026-006 河南硅烷科技发展股份有限公司 2025 年年度业绩预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 特别提示：本公告所载 2025 年年度主要财务数据为初步核算数据，未经会 计师事务所审计，具体数据以公司 2025 年年度报告中披露的数据为准，提请投 资者注意投资风险。 一、本期业绩预告情况 (一)业绩预告期间 二、本期业绩重大变化的主要原因 2025 年，受硅烷气行业产能快速扩张、下游光伏市场需求增速放缓影响， 行业阶段性供需失衡导致市场竞争加剧，产品价格同比大幅下降，公司报告期内 业绩亏损。具体情况如下： 1.公司主要产品硅烷气受到国内产能持续释放、光伏等主要下游行业需求增 长放缓的影响，市场出现阶段性供需失衡。报告期内产品价格大幅下降，营业收 入较上年同期出现明显下降，并且硅粉等原材料降幅远低于产品价格降幅，导致 利润同比大幅下降，业绩亏损。 2.根据 2025 年度应收账款实际回款情况，公司进行了综合分析和审慎考虑， ...

Financial Performance - The company expects a net profit of approximately -110 million yuan for the fiscal year 2025, representing a decline of 1,428.06% compared to the same period last year[4] - The basic earnings per share are projected to be -2.74 yuan, compared to -1.84 yuan in the previous year[6] Asset Impairment - The impairment loss on the construction of the PBAT integration project is estimated to be around 800 to 1,000 million yuan[8] - Fixed asset impairment related to real estate in Beijing is estimated at 20.41 million yuan[9] - The final assessment results regarding asset impairment testing are still pending[10] Financing and Expenses - Interest expenses related to the financing of the PBAT integration project amount to 12.9 million yuan, which will be fully expensed[9] - The company has recognized bad debt losses of 31.62 million yuan related to its supply chain and trade business[9] Sales and Operations - Sales volume of civil explosives has decreased due to a year-on-year decline in raw coal production in the operational area[9] Cautionary Notes - The financial data in this earnings forecast has not been audited by an external accounting firm[10] - Investors are advised to be cautious of investment risks due to the preliminary nature of the financial estimates[10]

证券代码：002168 证券简称：*ST惠程 公告编号：2026－002 2025年度业绩预告 1.业绩预告期间：2025年1月1日至2025年12月31日。 2.业绩预告情况：预计净利润为负值、股票交易已被实施财务类退市风险警 示后的首个会计年度。 （1）以区间数进行业绩预告的： 单位：万元 | 项目 | 本会计年度 | | | 上年同期 | | --- | --- | --- | --- | --- | | 利润总额 | -7,000.00 | ～ | -3,500.00 | -12,393.06 | | 归属于上市公司股东的净利润 | -10,000.00 | ～ | -6,000.00 | -14,952.20 | | 扣除非经常性损益后的净利润 | -10,500.00 | ～ | -6,500.00 | -16,931.41 | | 基本每股收益（元/股） | -0.1275 | ～ | -0.0765 | -0.1907 | | 营业收入 | 36,000.00 | ～ | 45,000.00 | 19,723.59 | | 扣除后营业收入 | 33,000.00 | ～ | 40,000.00 ...

Financial Performance - The company expects a net profit attributable to shareholders of approximately -28 million yuan for the reporting period, compared to -19 million yuan in the same period last year, indicating a narrowing of losses [4]. - The net profit after deducting non-recurring gains and losses is projected to be around -31 million yuan, compared to -22 million yuan in the previous year [4]. - The basic earnings per share are expected to be around -0.3427 yuan, compared to -0.2326 yuan in the previous year [4]. - The performance forecast is based on preliminary estimates and has not been audited, urging investors to exercise caution [9]. Non-Recurring Gains and Losses - The company anticipates non-recurring gains and losses to amount to approximately 30 million yuan, primarily from government subsidies [7]. Strategic Development - The company is implementing a national development strategy focusing on deepening its presence in Southwest China, advancing into the Greater Bay Area, and expanding in East China [8]. - The newly established intelligent dairy product central factory in Fuyang, Anhui, is the largest and most advanced buffalo milk production base in East China, enhancing market coverage across seven provinces [8]. - The company is optimizing its operational strategies and focusing on its core water buffalo milk business to drive growth [7]. Audit and Compliance - The company has communicated with its auditing firm regarding the financial data, and there are no discrepancies reported [5]. Innovation and Milestones - The company has successfully achieved a milestone in breeding high-yield buffalo embryos, marking a breakthrough in overcoming the bottleneck of buffalo genetic resources in China [7].

证券代码：300148 证券简称：天舟文化 编号：2026-006 天舟文化股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或者重大遗漏。 一、本期业绩预计情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 注：本公告格式中的"元"均指人民币元。 二、与会计师事务所沟通情况 本次业绩预告相关的财务数据未经注册会计师审计。公司就业绩 预告有关事项与会计师事务所进行了预沟通，双方在本次业绩预告方 面不存在重大分歧。 三、业绩变动原因说明 1、2025 年度收入和净利润均同比增长，主要原因是公司青少年 类图书、移动网络游戏的收入和毛利同比增加；确认的投资收益同比 增加等所致。 2、预计公司 2025 年度非经常性损益对净利润的影响金额为 600-1100 万元，上年同期为 460.74 万元。 四、其他相关说明 本次业绩预告相关的财务数据是公司财务部门初步测算的结果， 具体财务数据将在 2025 年度报告中详细披露。敬请广大投资者注意 投资风险。 特此公告。 天舟文化股份有限公司董事会 （二）业绩预告 ...

Financial Performance - The company expects a net profit attributable to shareholders to be a loss of between 180 million and 360 million yuan, compared to a loss of 385.99 million yuan in the same period last year[3]. - The expected net profit after deducting non-recurring gains and losses is projected to be a loss of between 200 million and 400 million yuan, compared to a loss of 190.84 million yuan in the previous year[3]. - Operating revenue is forecasted to be between 1.38 billion and 1.46 billion yuan, slightly down from 1.43 billion yuan in the same period last year[3]. - The estimated impairment loss for long-term equity investments and intangible assets is projected to be between 260 million and 420 million yuan, subject to final audit confirmation[5]. - Non-recurring gains and losses are expected to be between 0 and 80 million yuan, a significant improvement from a loss of 195.15 million yuan in the previous year[6]. Cash Flow and Financial Support - The net cash flow from operating activities has shown significant growth compared to the previous year, providing solid financial support for sustainable development[4]. Market Expansion and Product Development - Revenue from overseas markets is expected to exceed 65% of total revenue, driven by the long-term operation of SLG products such as "War and Eternity" and "Game of Thrones: Winter is Coming"[5]. - The company has successfully entered the mini-game market with self-developed products, including "Young Three Kingdoms - Nostalgia Edition," and is building a product matrix for domestic business growth[5]. Financial Data Disclosure - The company emphasizes the preliminary nature of the financial data, which has not yet been audited, and will provide detailed disclosures in the 2025 annual report[7].

证券代码：000488 200488 证券简称：ST 晨鸣 ST 晨鸣 B 公告编号：2026-001 山东晨鸣纸业集团股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、本期业绩预计情况 （一）业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日 （二）业绩预告情况：预计净利润为负值 | 项目 | | 本报告期 | | | 上年同期 | | | --- | --- | --- | --- | --- | --- | --- | | 归属于上市公司股东的净利润 | 亏损：820,000 | | 万元–880,000 | 万元 | 亏损：741,078 | 万元 | | 扣除非经常性损益后的净利润 | 亏损：755,000 | | 万元–815,000 | 万元 | 亏损：720,239 | 万元 | | 基本每股收益 | 亏损：2.79 | | 元/股–3.00 元/股 | | 亏损：2.53 | 元/股 | 本次业绩预告的相关财务数据未经注册会计师审计，公司已就业绩预告有关事项 与年审会计师事务 ...

Financial Performance - The company expects a net profit loss of approximately -16,800万元 for the year 2025, compared to a loss of -11,500万元 in the previous year[5] - The net profit after deducting non-recurring gains and losses is projected to be -17,530万元, down from -12,230万元 year-over-year[5] - The company has incurred significant share-based payment expenses due to stock incentive plans, impacting overall performance[7] - The company is facing losses due to impairment provisions for fixed assets and inventory based on market value assessments[7] Market Conditions - The decline in sales scale and gross margin is attributed to global economic slowdown, trade barriers, and intense market competition[7] Strategic Plans - The company plans to enhance profitability through strategic adjustments, technological innovation, and expansion into new overseas markets[7] Financial Reporting - The financial data in the earnings forecast has not been audited by an external accounting firm[6] - The specific financial figures for 2025 will be detailed in the annual report, with actual data prevailing[8] - The earnings forecast period is from January 1, 2025, to December 31, 2025[3] - The board of directors guarantees the accuracy and completeness of the information disclosed in the earnings forecast[2]

证券代码：002030 证券简称：达安基因 公告编号：2026-003 广州达安基因股份有限公司 2025年年度业绩预告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 （一）业绩预告期间：2025年1月1日–2025年12月31日。 （二）业绩预告情况：预计净利润为负值 | 项目 | 本报告期 | 上年同期 | | | --- | --- | --- | --- | | 归属于上市公司股 东的净利润 | 万元 -86,500.00 万元至-60,700.00 | -92,516.99 | 万元 | | 扣除非经常性损益 后的净利润 | 万元至-65,800.00 万元 -93,800.00 | -82,265.31 | 万元 | | 基本每股收益 | 元/股至-0.43 元/股 -0.62 | -0.66 | 元/股 | 二、与会计师事务所沟通情况 本次业绩预告相关数据未经会计师事务所审计。公司就业绩预告有关事项已 与会计师事务所进行预沟通，公司与会计师事务所关于本次业绩预告事项不存在 分歧。 三、业绩变动原因说明 公司2025年度业绩 ...